Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pulsatile GnRH in Anovulatory Infertility
NCT00383656Phase 2Unknown
- Sponsor
- Massachusetts General Hospital
- Start
- Jan 1989
- Primary completion
- Sep 2020
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of gonadorelin in infertility and hypogonadotropic hypogonadism (HH), sponsored by Massachusetts General Hospital. Primary endpoint: Ovulation. Status: unknown.
02
Drugs
gonadorelin
03
Conditions
infertilityhypogonadotropic hypogonadism (HH)
Beyond the preview
Go deeper on NCT00383656.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00383656.